Pulse8 Announces New Chief Medical Officer
Christopher L. Vojta, M.D., M.B.A., M.S.C.E. to Support Risk Adjustment
Activities and Oversight of Clinical Outcomes
ANNAPOLIS, Md., March 13, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Pulse8 Inc., a
cutting-edge big data healthcare analytics and technology company focused on
risk adjustment solutions for the Commercial Health Exchanges (HIX) and
Medicare Advantage markets announced today that it appointed Dr. Christopher
Vojta as its Chief Medical Officer.
Dr. Vojta will provide strategic direction and support of the design,
implementation, and adoption of cutting-edge healthcare technology and
analytics products serving the Commercial Health Exchange and Medicare
Advantage markets. He will also represent Pulse8's mission and values in the
oversight of risk adjustment, medical management, case and disease management,
utilization review, and all decisions with clinical impact.
Dr. Vojta has 15 years of experience in various senior positions in health
care including UnitedHealth Group, Deloitte Consulting and Wyeth
Pharmaceuticals. In his leadership roles, he successfully launched major
product innovations including Medicare Advantage Chronic Illness Special Needs
Plans, ran the Medical Management Practice of Deloitte Consulting, and
launched a Medical Management IT Consulting Practice. In addition, he was head
of U.S. Medical Affairs for Wyeth, which included all of Global Health
Outcomes Research, Opinion Leaders, U.S. Medical Science Liaison Group and
U.S. Call Center.
"The appointment of Chris Vojta as Chief Medical Officer reflects Pulse8's
leadership position as health plans across the country rely on our products
and expertise to ensure precision in their big data, analytics, and risk
adjustment initiatives", commented John Criswell, Founder and CEO. "As the big
data and analytics leader, our integrated approach and clinical value for our
customers will be strengthened by Dr. Vojta's experience."
In accepting this position, Dr. Vojta commented: "Customers can rely on the
fact that Pulse8 has the best identification, stratification and sequencing
software in the industry. In this new era of health care, plans have no choice
but to be very selective in deciding which interventions to deploy. Pulse8
software offers unique analytics and visualization to detect and drive the
least costly intervention achieving the highest financial performance."
Dr. Vojta is a graduate of Yale University and holds MD, MBA and MS in
Clinical Epidemiology from the University of Pennsylvania's Wharton School and
Medical School. In addition, he serves on several boards.
About Pulse8 Inc.
Pulse8 is a cutting-edge healthcare technology and analytics provider that
delivers an unprecedented view into risk adjustment so health plans can
achieve the highest financial impact in the Commercial Health Exchanges (HIX)
and Medicare Advantage markets. Its proprietary algorithms move beyond
traditional methods and data sources to make predictions about what individual
members require next, ultimately closing gaps in care and increasing precision
with risk adjustment initiatives. Pulse8 offers innovative and unique
methodologies in its Risk Adjustment Analytics Suite to ensure its clients
outperform the marketplace. Its transparent and flexible business intelligence
tools give real-time visibility into member and provider behaviors allowing
clients to apply the most cost-effective and appropriate interventions. For
more company information, please contact Pulse8 at (410) 928.4218 or visit
http://www.Pulse8.com and follow Pulse8 on Twitter @Pulse8News
This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit
CONTACT: Pulse8 Inc.
+1 (443) 223-2271
Press spacebar to pause and continue. Press esc to stop.